Provenienza dei contatti di primo grado di Karine Rossignol
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Smart Immune SAS
 Smart Immune SAS BiotechnologyHealth Technology Smart Immune SAS is a clinical-stage biotechnology company based in Paris, France. Smart Immune is developing Protcell, a thymus-empowered T cell progenitor therapy platform to re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies for all. The French company aims to improve outcomes for patients with life-threatening diseases such as high-risk blood cancers and primary immunodeficiencies. Smart Immune has ongoing collaborations with leading institutions in the EU and the US. Smart101 is already in phase I/II clinical trials in the EU and the US, looking at the acceleration of complete immune recovery in patients fighting cancer and infection and undergoing allogeneic hematopoietic stem cell transplantation. Smart Immune is also developing therapies using gene-modified T cell progenitors through its Protcell platform to provide targeted treatments against cancer, like persistent off-the-shelf CAR T cells. The company is headquartered at Biotech Santé. The company was founded in 2017 by Karine Rossignol, Marina Cavazzana, Isabelle André, with Karine Rossignol as the CEO since 2017.
5
| Holding Company | Biotechnology | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Karine Rossignol tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ZS PHARMA INC | Pharmaceuticals: Major | Chief Executive Officer | |
| VALTECH | Packaged Software | Chief Executive Officer | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Chief Executive Officer | |
| THERADIAG | Medical Specialties | Director/Board Member | |
| Université François-Rabelais de Tours | College/University | Doctorate Degree | |
| AB SCIENCE | Pharmaceuticals: Other | Director/Board Member | |
| Grenoble Ecole de Management | College/University | Masters Business Admin | |
Valtech Technologies, Inc.
 Valtech Technologies, Inc. Information Technology ServicesTechnology Services Valtech Technologies, Inc. provides agile software development and digital technologies and services. The company was founded in 1993 and is headquartered in Dallas, Texas. | Information Technology Services | Chief Executive Officer | |
SiegCo SA
 SiegCo SA Packaged SoftwareTechnology Services SiegCo SA provides software development, information technology, and e-business consulting services. The company was founded on March 23, 2005 and is headquartered in Brussels, Belgium. | Packaged Software | Director/Board Member | |
A3 Investments
 A3 Investments Financial ConglomeratesFinance A3 Investments is a Belgian company that operates in the management of companies and enterprises industry. | Financial Conglomerates | Corporate Officer/Principal | |
| SENSORION | Pharmaceuticals: Major | Director/Board Member | |
CarThera SAS
 CarThera SAS Medical SpecialtiesHealth Technology CarThera SAS develops ultrasound based medical devices to treat brain disorders. The firm offers SonoProbe and SonoCloud. The company was founded by Alexandre Carpentier on February 8, 2010 and is headquartered in Paris, France. | Medical Specialties | Chairman | |
| Valtech Training | Chairman | ||
| Valtech Technology Consulting | Chairman | ||
| Valtech Hong Kong Ltd. | Director/Board Member | ||
| Valtech Co. Ltd. | Director/Board Member | ||
| Valtech AG | Director/Board Member | ||
| Novedia SAS | Director/Board Member | ||
Cosmoledo Sprl
 Cosmoledo Sprl Financial ConglomeratesFinance Cosmoledo Sprl is an investment holding Italian company. | Financial Conglomerates | Corporate Officer/Principal | |
| Dominus SA | Director/Board Member | ||
| Skyjet Ltd. | Director/Board Member | ||
| Statler & Waldorf SAS | Chairman | ||
| Dendrobium | Director/Board Member | ||
| THERANEXUS | Pharmaceuticals: Major | Director/Board Member | |
| MINERVA NEUROSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ABIVAX | Pharmaceuticals: Other | Director/Board Member | |
| Only For Children Pharmaceuticals SA | Director/Board Member | ||
| OSE Pharmaceuticals | Chief Executive Officer | ||
| OSE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Founder | |
DalCor Pharmaceuticals Canada, Inc.
 DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology DalCor Pharmaceuticals Canada, Inc. develops precision treatments for cardiovascular diseases. It offers dalcetrapib, a cholesterol ester transfer protein (CETP) inhibitor, as a potential targeted treatment to address the residual cardiovascular risk in patients carrying a specific ADCY9 genetic profile. The company was founded by Andr? Roger Desmarais and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Chief Executive Officer | |
Horama SA
 Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
Valtech SE
 Valtech SE Miscellaneous Commercial ServicesCommercial Services Valtech SE operates as a digital agency. It offers omni-channel, analytics and big data, customer responsive platforms, agile marketing, internet of things, digital marketing, and digital video streaming services. The company was founded in 1993 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer | |
Nuro Corp.
 Nuro Corp. Packaged SoftwareTechnology Services Nuro Corp. provides neurological communication software. The company was founded by Francois Gand, Abhinav Kumar and Pascal Gand and is headquartered in Waterloo, Canada. | Packaged Software | Director/Board Member | |
Cellaïon SA
 Cellaïon SA BiotechnologyHealth Technology Cellaïon SA is a biotech company located in Mont Saint Guibert, Belgium. Cellaïon aims to restore a favorable environment to reboost the regenerative process of the liver and ensure a second life to the native liver instead of losing it. The Belgian company has a strong IP base issued from their own research and academic research at UCLouvain, developed with the objective to generate new products. Cellaïon's treatment covers the wide spectrum of liver diseases, from the highly life-threatening acute-on-chronic liver-failure (ACLF) and acute alcoholic hepatitis, to intermediate severity acute decompensation of cirrhosis (AD) and progressive chronic liver diseases caused by non-alcoholic steatohepatitis (NASH). The company has built up a series of R&D and collaborative partnerships with both industrial and academic partners, allowing Cellaïon to broaden and accelerate its clinical development. The company was founded by Etienne Marc Sokal, who has been the CEO since incorporation. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
| Francia | 27 |
| Belgio | 5 |
| Stati Uniti | 4 |
| Canada | 3 |
| Regno Unito | 2 |
Settori
| Health Technology | 17 |
| Technology Services | 6 |
| Consumer Services | 4 |
| Finance | 3 |
| Commercial Services | 2 |
Posizioni
| Director/Board Member | 26 |
| Chief Executive Officer | 10 |
| Chairman | 10 |
| Independent Dir/Board Member | 8 |
| Founder | 7 |
Contatti più connessi
- Borsa valori
- Insiders
- Karine Rossignol
- Connessioni Società
